Skip to main content

A Multicenter Phase 3 Trial of Lobeline Sulfate for Smoking Cessation

Buy Article:

$39.00 plus tax (Refund Policy)

Abstract:

Objective: To evaluate the safety and efficacy of sublingual lobeline sulfate for smoking cessation.

Methods: A multicenter (3 sites), double-blind, parallel, placebo-controlled, phase 3 smoking cessation trial of sublingual formulation of lobeline sulfate. A total of 750 smokers (250 per site) were randomized to either treatment (lobeline sulfate) or placebo with individual smoking cessation counseling lasting up to approximately 10 minutes.

Results: Efficacy revealed no statistical significance (P = 0.62) for lobeline sulfate as a smoking cessation aid.

Conclusion: Sublingual formulation of lobeline sulfate does not appear to be an effective smoking cessation aid.

Keywords: clinical trials; lobeline sulfate; smoking cessation

Document Type: Research Article

DOI: http://dx.doi.org/10.5993/AJHB.34.1.12

Publication date: January 1, 2010

More about this publication?
  • The American Journal of Health Behavior seeks to improve the quality of life through multidisciplinary health efforts in fostering a better understanding of the multidimensional nature of both individuals and social systems as they relate to health behaviors.

    The Journal aims to provide a comprehensive understanding of the impact of personal attributes, personality characteristics, behavior patterns, social structure, and processes on health maintenance, health restoration, and health improvement; to disseminate knowledge of holistic, multidisciplinary approaches to designing and implementing effective health programs; and to showcase health behavior analysis skills that have been proven to affect health improvement and recovery.

  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Review Board
  • Reprints and Permissions
  • Ingenta Connect is not responsible for the content or availability of external websites
png/ajhb/2010/00000034/00000001/art00012
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more